CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GemPharmatech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GemPharmatech Co Ltd
No. 12 Xuefu Road, Jiangbei New Area
Phone: +86 2558243997p:+86 2558243997 NANJING, JNG  210032  China Ticker: 688046688046

Business Summary
GemPharmatech Co Ltd is a China-based company primarily engaged in the research and development, creation, production, sales and related technical services of experimental animal models. The Company’s main products include knockout and conditional knockout mouse models, immunodeficient mouse models, humanized mouse models, disease mouse models, germ-free mouse models and other products. The Company is also engaged in providing custom model generation, custom breeding, one-stop functional efficacy analysis services, and one-stop services from target concept verification to investigational new drug (IND) submission. The Company conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board XiangGao
Chief Financial Officer XiaoshanJiao 48
Chief Operating Officer, Deputy General Manager ZhongyuLi
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,506 (As of 12/31/2023)
Outstanding Shares: 410,000,000 (As of 10/31/2024)
Shareholders: 6,339
Stock Exchange: SHA
Fax Number: +86 2558265927


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025